Effects of DQ-2511 on neutral activity in afferent and efferent loops of gastric vago-vagal reflex pathways in the rat.
1. DQ-2511 is a new substituted benzamide compound that has gastric prokinetic properties. Actions of the drug on neural discharge in the innervation of the stomach of anaesthetized rats were studied. Standard extracellular methods of multi-unit recording were used to study rates of firing in afferent and efferent filaments teased from gastric branches of the vague nerve. 2. Decreased firing in gastric vagal efferents was associated with increased rates of discharge in the gastric afferents. 3. Intravenous application of DQ-2511 resulted in increased frequency of firing in the efferents in association with decreased rate of discharge in afferent fibres. 4. Application of cholecystokinin octapeptide (CCK8) suppressed activity in the gastric efferents which occurred coincident with the elevated discharge in the afferents. Pretreatment with DQ-2511 blocked the actions of CCK8. 5. The results suggest that the gastric prokinetic action of DQ-2511 may involve suppression of activation of afferents in the sensory component of gastric inhibitory vago-vagal reflex pathways.
Niijima
A
A
Department of Physiology, Niigata University School of Medicine, Japan.
Hatanaka
S
S
Furuhama
K
K
D000344:Afferent Pathways / Q000187:drug effects; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology*; D004525:Efferent Pathways / Q000187:drug effects; D004558:Electric Stimulation; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012018:Reflex / Q000187:drug effects*; D012844:Sincalide / Q000037:antagonists & inhibitors*; D013270:Stomach / Q000294:innervation*; D014630:Vagus Nerve / Q000187:drug effects*
D000897:Anti-Ulcer Agents; D001549:Benzamides; C058308:ecabapide; D012844:Sincalide